Sorrentino, M.; Capretti, G.; Nappo, G.; Gavazzi, F.; Ridolfi, C.; Pagnanelli, M.; Nebbia, M.; Morelli, P.; Zerbi, A.
Origin and Clinical Impact of Early Multidrug-Resistant (MDR) Contamination in Patients Undergoing Pancreaticoduodenectomy. Gastroenterol. Insights 2024, 15, 168-178.
https://doi.org/10.3390/gastroent15010012
AMA Style
Sorrentino M, Capretti G, Nappo G, Gavazzi F, Ridolfi C, Pagnanelli M, Nebbia M, Morelli P, Zerbi A.
Origin and Clinical Impact of Early Multidrug-Resistant (MDR) Contamination in Patients Undergoing Pancreaticoduodenectomy. Gastroenterology Insights. 2024; 15(1):168-178.
https://doi.org/10.3390/gastroent15010012
Chicago/Turabian Style
Sorrentino, Martina, Giovanni Capretti, Gennaro Nappo, Francesca Gavazzi, Cristina Ridolfi, Michele Pagnanelli, Martina Nebbia, Paola Morelli, and Alessandro Zerbi.
2024. "Origin and Clinical Impact of Early Multidrug-Resistant (MDR) Contamination in Patients Undergoing Pancreaticoduodenectomy" Gastroenterology Insights 15, no. 1: 168-178.
https://doi.org/10.3390/gastroent15010012
APA Style
Sorrentino, M., Capretti, G., Nappo, G., Gavazzi, F., Ridolfi, C., Pagnanelli, M., Nebbia, M., Morelli, P., & Zerbi, A.
(2024). Origin and Clinical Impact of Early Multidrug-Resistant (MDR) Contamination in Patients Undergoing Pancreaticoduodenectomy. Gastroenterology Insights, 15(1), 168-178.
https://doi.org/10.3390/gastroent15010012
